Bioharvest Sciences [BHST] vs BRC [BRCC] Detailed Stock Comparison

Bioharvest Sciences Inc.

NASDAQ
Loading...

BRC Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 19 vital metrics comparison: Bioharvest Sciences Inc. wins in 6 metrics, BRC Inc. wins in 13 metrics, with 0 ties. BRC Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Bioharvest Sciences Inc. BRC Inc. Better
P/E Ratio (TTM) -7.30 -8.38 Bioharvest Sciences Inc.
Price-to-Book Ratio 3.90 2.72 BRC Inc.
Debt-to-Equity Ratio 55.42 91.21 Bioharvest Sciences Inc.
PEG Ratio -51.53 36.00 BRC Inc.
EV/EBITDA -17.68 -17.93 Bioharvest Sciences Inc.
Profit Margin (TTM) -32.27% -2.99% BRC Inc.
Operating Margin (TTM) -12.37% -2.08% BRC Inc.
Return on Equity -83.17% -54.86% BRC Inc.
Return on Assets (TTM) -9.59% -4.65% BRC Inc.
Free Cash Flow (TTM) $-9.58M $-13.47M Bioharvest Sciences Inc.
1-Year Return -38.34% -8.38% BRC Inc.
Price-to-Sales Ratio (TTM) 2.88 0.32 BRC Inc.
Enterprise Value $90.35M $204.49M BRC Inc.
EV/Revenue Ratio 2.62 0.51 BRC Inc.
Gross Profit Margin (TTM) 57.63% 32.07% Bioharvest Sciences Inc.
Revenue per Share (TTM) $2 $4 BRC Inc.
Earnings per Share (Diluted) $-0.60 $-0.13 BRC Inc.
Beta (Stock Volatility) 1.40 0.76 BRC Inc.
Short % of Float 0.34% 10.26% Bioharvest Sciences Inc.

Bioharvest Sciences Inc. vs BRC Inc. Stock Performance Analysis

Loading Price Chart...

BHST
BRCC

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Bioharvest Sciences Inc.-1.66%-9.18%-14.01%-19.09%-45.40%-31.67%
BRC Inc.-3.85%-12.79%37.61%85.19%14.50%33.93%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Bioharvest Sciences Inc.-38.34%-35.67%-35.67%-35.67%-35.67%-35.67%
BRC Inc.-8.38%-70.13%-89.93%-89.93%-89.93%-89.93%

Performance & Financial Health Analysis: Bioharvest Sciences Inc. vs BRC Inc.

MetricBHSTBRCC
Market Information
Market Cap i$99.29M$129.29M
Market Cap CategoryMicro capMicro cap
10 Day Avg. Volume i14,610428,384
90 Day Avg. Volume i23,620526,545
Last Close$3.56$1.50
52 Week Range$3.54 - $12.80$0.60 - $2.10
% from 52W High-72.19%-28.57%
All-Time High$12.80 (Oct 07, 2025)$34.00 (Apr 11, 2022)
% from All-Time High-72.19%-95.59%
Growth Metrics
Quarterly Revenue Growth0.25%0.07%
Quarterly Earnings Growth0.25%0.06%
Financial Health
Profit Margin (TTM) i-0.32%-0.03%
Operating Margin (TTM) i-0.12%-0.02%
Return on Equity (TTM) i-0.83%-0.55%
Debt to Equity (MRQ) i55.4291.21
Cash & Liquidity
Book Value per Share (MRQ)$1.12$0.40
Cash per Share (MRQ)$1.02$0.04
Operating Cash Flow (TTM) i$-7,226,000$-9,810,000
Levered Free Cash Flow (TTM) i$-10,782,250$-1,676,125
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Bioharvest Sciences Inc. vs BRC Inc.

MetricBHST (Apr 26, 2026)BRCC (Apr 24, 2026)
Price Ratios
P/E Ratio (TTM) i-7.30-8.38
Forward P/E i-51.5336.00
PEG Ratio i-51.5336.00
Price to Sales (TTM) i2.880.32
Price to Book (MRQ) i3.902.72
Market Capitalization
Market Capitalization i$99.29M$129.29M
Enterprise Value i$90.35M$204.49M
Enterprise Value Metrics
Enterprise to Revenue i2.620.51
Enterprise to EBITDA i-17.68-17.93
Risk & Other Metrics
Beta i1.400.76
Book Value per Share (MRQ) i$1.12$0.40

Financial Statements Comparison: Bioharvest Sciences Inc. vs BRC Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricBHST (2025)BRCC (2025)
Revenue/Sales i34.51M398.26M
Cost of Goods Sold i14.03M260.32M
COGS % of Revenue i40.7%65.4%
Gross Profit i20.48M137.95M
Gross Margin i59.3%34.6%
Research & Development i5.31MN/A
Operating Income (EBIT) i-5.58M-24.60M
Operating Margin i-16.2%-6.2%
EBITDA i-4.88M-12.40M
EBITDA Margin i-14.1%-3.1%
Pre-Tax Income i-11.06M-32.10M
Pre-Tax Income % of Revenue i-32.0%-8.1%
Income Tax i76,000132,000
Income Tax % of Revenue i0.2%0.0%
Net Income (Profit) i-11.14M-32.24M
Profit Margin i-32.3%-8.1%

Balance Sheet & Liquidity Metrics

MetricBHST (2025)BRCC (2025)
Cash & Equivalents i23.03M4.33M
Total Current Assets i30.50M100.33M
Total Current Assets % of Revenue i88.4%25.2%
Total Current Liabilities i7.68M76.09M
Total Current Liabilities % of Revenue i22.3%19.1%
Long-Term Debt i12.55M57.15M
Long-Term Debt % of Revenue i36.4%14.3%
Total Shareholders Equity i25.45M68.02M
Retained Earnings i-107.55M-135.34M
Retained Earnings % of Revenue i-311.7%-34.0%
Property, Plant & Equipment i830,00021.21M

Cash Flow Statement Comparison

MetricBHST (2025)BRCC (2025)
Operating Cash Flow i-7.71M-29.12M
Operating Cash Flow % of Revenue i-22.3%-7.3%
Capital Expenditures i-2.36M1.42M
Free Cash Flow i-9.58M-13.47M
FCF Margin i-27.8%-3.4%
Debt Repayment i-7.15M-280.76M
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricBHSTBRCC
Shares Short i65,2928.23M
Short Ratio i2.418.40
Short % of Float i0.34%10.26%
Shares Outstanding i22.67M114.86M
Float Shares i17.82M71.21M
% Held by Insiders i16.60%23.70%
% Held by Institutions i8.28%58.03%
% Held by Public i75.12%18.27%

Dividend Analysis & Yield Comparison: Bioharvest Sciences Inc. vs BRC Inc.

MetricBHSTBRCC
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A